A decision-tree approach for the differential diagnosis of chronic lymphoid leukemias and peripheral B-cell lymphomas.


Journal

Computer methods and programs in biomedicine
ISSN: 1872-7565
Titre abrégé: Comput Methods Programs Biomed
Pays: Ireland
ID NLM: 8506513

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 04 12 2018
revised: 07 06 2019
accepted: 12 06 2019
entrez: 17 8 2019
pubmed: 17 8 2019
medline: 23 2 2020
Statut: ppublish

Résumé

Here we propose a decision-tree approach for the differential diagnosis of distinct WHO categories B-cell chronic lymphoproliferative disorders using flow cytometry data. Flow cytometry is the preferred method for the immunophenotypic characterization of leukemia and lymphoma, being able to process and register multiparametric data about tens of thousands of cells per second. The proposed decision-tree is composed by logistic function nodes that branch throughout the tree into sets of (possible) distinct leukemia/lymphoma diagnoses. To avoid overfitting, regularization via the Lasso algorithm was used. The code can be run online at https://codeocean.com/2018/03/08/a-decision-tree-approach-for-the-differential-diagnosis-of-chronic-lymphoid-leukemias-and-peripheral-b-cell-lymphomas/ or downloaded from https://github.com/lauramoraes/bioinformatics-sourcecode to be executed in Matlab. The proposed approach was validated in diagnostic peripheral blood and bone marrow samples from 283 mature lymphoid leukemias/lymphomas patients. The proposed approach achieved 95% correctness in the cross-validation test phase (100% in-sample), 61% giving a single diagnosis and 34% (possible) multiple disease diagnoses. Similar results were obtained in an out-of-sample validation dataset. The generated tree reached the final diagnoses after up to seven decision nodes. Here we propose a decision-tree approach for the differential diagnosis of mature lymphoid leukemias/lymphomas which proved to be accurate during out-of-sample validation. The full process is accomplished through seven binary transparent decision nodes.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
Here we propose a decision-tree approach for the differential diagnosis of distinct WHO categories B-cell chronic lymphoproliferative disorders using flow cytometry data. Flow cytometry is the preferred method for the immunophenotypic characterization of leukemia and lymphoma, being able to process and register multiparametric data about tens of thousands of cells per second.
METHODS METHODS
The proposed decision-tree is composed by logistic function nodes that branch throughout the tree into sets of (possible) distinct leukemia/lymphoma diagnoses. To avoid overfitting, regularization via the Lasso algorithm was used. The code can be run online at https://codeocean.com/2018/03/08/a-decision-tree-approach-for-the-differential-diagnosis-of-chronic-lymphoid-leukemias-and-peripheral-b-cell-lymphomas/ or downloaded from https://github.com/lauramoraes/bioinformatics-sourcecode to be executed in Matlab.
RESULTS RESULTS
The proposed approach was validated in diagnostic peripheral blood and bone marrow samples from 283 mature lymphoid leukemias/lymphomas patients. The proposed approach achieved 95% correctness in the cross-validation test phase (100% in-sample), 61% giving a single diagnosis and 34% (possible) multiple disease diagnoses. Similar results were obtained in an out-of-sample validation dataset. The generated tree reached the final diagnoses after up to seven decision nodes.
CONCLUSIONS CONCLUSIONS
Here we propose a decision-tree approach for the differential diagnosis of mature lymphoid leukemias/lymphomas which proved to be accurate during out-of-sample validation. The full process is accomplished through seven binary transparent decision nodes.

Identifiants

pubmed: 31416565
pii: S0169-2607(18)31736-X
doi: 10.1016/j.cmpb.2019.06.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

85-90

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

L O Moraes (LO)

Rua Horacio Macedo 2030, Rio de Janeiro/RJ, CEP: 21941-914, Brazil. Electronic address: lmoraes@cos.ufrj.br.

C E Pedreira (CE)

Rua Horacio Macedo 2030, Rio de Janeiro/RJ, CEP: 21941-914, Brazil. Electronic address: pedreira56@gmail.com.

S Barrena (S)

Lab 11, Centro de Investigacion del Cancer, Paseo de la Universidad de Coimbra, Campus Miguel Unamuno, 37002 Salamanca, España. Electronic address: subadelfa@usal.es.

A Lopez (A)

Lab 11, Centro de Investigacion del Cancer, Paseo de la Universidad de Coimbra, Campus Miguel Unamuno, 37002 Salamanca, España. Electronic address: antuam@usal.es.

A Orfao (A)

Lab 11, Centro de Investigacion del Cancer, Paseo de la Universidad de Coimbra, Campus Miguel Unamuno, 37002 Salamanca, España. Electronic address: orfao@usal.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH